prostate cancer

You have access
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Clément Morgat, Heying Duan, Simone Dalm, Elif Hindié, Thomas Günther, Bernd J. Krause, Vasko Kramer, Florine Cavelier, Andrew W. Stephens, Stephen Moran, Laura Lamb and Andrei Iagaru

Journal of Nuclear Medicine May 8, 2025, jnumed.124.269444; DOI: https://doi.org/10.2967/jnumed.124.269444
You have access
Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [⁶⁸Ga]Ga-PSMA-11 PET/CT in the proPSMA Study
David C. Chen, James P. Buteau, Louise Emmett, Ramin Alipour, Felipe de Galiza Barbosa, Matthew J. Roberts, Aoife McVey, Jonathan O’Brien, Sidney Levy, Roslyn J. Francis, Nathan Lawrentschuk, Declan G. Murphy and Michael S. Hofman

Journal of Nuclear Medicine May 1, 2025, 66 (5) 713-718; DOI: https://doi.org/10.2967/jnumed.124.268901
You have access
A Phase I/II Study of [¹⁷⁷Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol
Sara Harsini, Maryam Soleimani, Don Wilson, Carlos Uribe, Heather Saprunoff, Ingrid Bloise and Francois Benard

Journal of Nuclear Medicine April 30, 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064
You have access
Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT
Mateus de Oliveira Taveira, Ali Aria Razmaria, Heiko Schoder and Randy Yeh

Journal of Nuclear Medicine April 10, 2025, jnumed.124.269361; DOI: https://doi.org/10.2967/jnumed.124.269361
You have access
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, James P. Buteau, Grace Kong, Ben Tran, Mohammad B. Haskali, Michael Fahey, Megan Crumbaker, Louise Emmett, Michael S. Hofman and Arun A. Azad

Journal of Nuclear Medicine April 1, 2025, 66 (4) 572-578; DOI: https://doi.org/10.2967/jnumed.124.269252
Open Access
Preclinical Evaluation of ¹⁷⁷Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy
Caroline Foxton, Bradley Waldron, Rikke Veggerby Grønlund, Jaime (Jim) Simón, Bart Cornelissen, Edward O’Neill and Daniel Stevens

Journal of Nuclear Medicine April 1, 2025, 66 (4) 599-604; DOI: https://doi.org/10.2967/jnumed.124.268508
You have access
Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and Their Prognostic Value in Radical Prostatectomy
Alexandros Moraitis, Theresa Kahl, Jens Kandziora, Walter Jentzen, David Kersting, Lukas Püllen, Henning Reis, Jens Köllermann, Claudia Kesch, Ulrich Krafft, Boris A. Hadaschik, Habib Zaidi, Ken Herrmann, Francesco Barbato, Wolfgang P. Fendler, Christopher Darr and Pedro Fragoso Costa

Journal of Nuclear Medicine March 1, 2025, 66 (3) 352-358; DOI: https://doi.org/10.2967/jnumed.124.268719
Open Access
Safety, Dosimetry, and Feasibility of [⁶⁸Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer
Liza Lindenberg, Thomas A. Hope, Frank I. Lin, Steven P. Rowe, Darko Pucar, Noella Gilbert, Daniela Chicco, Beilei He, Benedikt Feuerecker, Elena Castaldi and Lilja B. Solnes

Journal of Nuclear Medicine March 1, 2025, 66 (3) 359-365; DOI: https://doi.org/10.2967/jnumed.124.268318
You have access
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
Suzanne van der Gaag, André N. Vis, Imke H. Bartelink, Josephina C.C. Koppes, Marina Hodolic, Harry Hendrikse and Daniela E. Oprea-Lager

Journal of Nuclear Medicine March 1, 2025, 66 (3) 373-376; DOI: https://doi.org/10.2967/jnumed.124.268340
You have access
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
Vishnu Murthy, Vinicius Ludwig, Andrei Gafita, Thomas A. Hope and Jeremie Calais

Journal of Nuclear Medicine February 27, 2025, jnumed.124.268818; DOI: https://doi.org/10.2967/jnumed.124.268818

Main menu

User menu

Search

prostate cancer

Pages